ClinicalTrials.govpublic full text
Immunogenicity and Reactogenicity Following a Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNtech) and Two Adjuvanted Sub-unit Vaccines (SP/GSK) Administered in Adults Who Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary Vaccination
covid-19, vaccine reaction, covid 19, mrna vaccines, immunology, sub-unit vaccine, booster, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 905641
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.